185 related articles for article (PubMed ID: 23204234)
1. DKK2 mediates osteolysis, invasiveness, and metastatic spread in Ewing sarcoma.
Hauer K; Calzada-Wack J; Steiger K; Grunewald TG; Baumhoer D; Plehm S; Buch T; Prazeres da Costa O; Esposito I; Burdach S; Richter GH
Cancer Res; 2013 Jan; 73(2):967-77. PubMed ID: 23204234
[TBL] [Abstract][Full Text] [Related]
2. The posterior HOXD locus: Its contribution to phenotype and malignancy of Ewing sarcoma.
von Heyking K; Roth L; Ertl M; Schmidt O; Calzada-Wack J; Neff F; Lawlor ER; Burdach S; Richter GH
Oncotarget; 2016 Jul; 7(27):41767-41780. PubMed ID: 27363011
[TBL] [Abstract][Full Text] [Related]
3. STEAP1 is associated with the invasive and oxidative stress phenotype of Ewing tumors.
Grunewald TG; Diebold I; Esposito I; Plehm S; Hauer K; Thiel U; da Silva-Buttkus P; Neff F; Unland R; Müller-Tidow C; Zobywalski C; Lohrig K; Lewandrowski U; Sickmann A; Prazeres da Costa O; Görlach A; Cossarizza A; Butt E; Richter GH; Burdach S
Mol Cancer Res; 2012 Jan; 10(1):52-65. PubMed ID: 22080479
[TBL] [Abstract][Full Text] [Related]
4. The endochondral bone protein CHM1 sustains an undifferentiated, invasive phenotype, promoting lung metastasis in Ewing sarcoma.
von Heyking K; Calzada-Wack J; Göllner S; Neff F; Schmidt O; Hensel T; Schirmer D; Fasan A; Esposito I; Müller-Tidow C; Sorensen PH; Burdach S; Richter GHS
Mol Oncol; 2017 Sep; 11(9):1288-1301. PubMed ID: 28319320
[TBL] [Abstract][Full Text] [Related]
5. G-Protein coupled receptor 64 promotes invasiveness and metastasis in Ewing sarcomas through PGF and MMP1.
Richter GH; Fasan A; Hauer K; Grunewald TG; Berns C; Rössler S; Naumann I; Staege MS; Fulda S; Esposito I; Burdach S
J Pathol; 2013 May; 230(1):70-81. PubMed ID: 23338946
[TBL] [Abstract][Full Text] [Related]
6. Cathepsin G enhances mammary tumor-induced osteolysis by generating soluble receptor activator of nuclear factor-kappaB ligand.
Wilson TJ; Nannuru KC; Futakuchi M; Sadanandam A; Singh RK
Cancer Res; 2008 Jul; 68(14):5803-11. PubMed ID: 18632634
[TBL] [Abstract][Full Text] [Related]
7. Stress-induced CXCR4 promotes migration and invasion of ewing sarcoma.
Krook MA; Nicholls LA; Scannell CA; Chugh R; Thomas DG; Lawlor ER
Mol Cancer Res; 2014 Jun; 12(6):953-64. PubMed ID: 24651452
[TBL] [Abstract][Full Text] [Related]
8. Oncostatin M is a growth factor for Ewing sarcoma.
David E; Tirode F; Baud'huin M; Guihard P; Laud K; Delattre O; Heymann MF; Heymann D; Redini F; Blanchard F
Am J Pathol; 2012 Nov; 181(5):1782-95. PubMed ID: 22982441
[TBL] [Abstract][Full Text] [Related]
9. EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma.
Garcia-Monclús S; López-Alemany R; Almacellas-Rabaiget O; Herrero-Martín D; Huertas-Martinez J; Lagares-Tena L; Alba-Pavón P; Hontecillas-Prieto L; Mora J; de Álava E; Rello-Varona S; Giangrande PH; Tirado OM
Int J Cancer; 2018 Sep; 143(5):1188-1201. PubMed ID: 29582409
[TBL] [Abstract][Full Text] [Related]
10. Lack of matrix metalloproteinase (MMP)-1 and -3 expression in Ewing sarcoma may be due to loss of accessibility of the MMP regulatory element to the specific fusion protein in vivo.
Yabe H; Fukuma M; Urano F; Yoshida K; Kato S; Toyama Y; Hata J; Umezawa A
Biochem Biophys Res Commun; 2002 Apr; 293(1):61-71. PubMed ID: 12054564
[TBL] [Abstract][Full Text] [Related]
11. WEE1 accumulation and deregulation of S-phase proteins mediate MLN4924 potent inhibitory effect on Ewing sarcoma cells.
Mackintosh C; García-Domínguez DJ; Ordóñez JL; Ginel-Picardo A; Smith PG; Sacristán MP; de Álava E
Oncogene; 2013 Mar; 32(11):1441-51. PubMed ID: 22641220
[TBL] [Abstract][Full Text] [Related]
12. Reactivation of TWIST1 contributes to Ewing sarcoma metastasis.
Choo S; Wang P; Newbury R; Roberts W; Yang J
Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28873262
[TBL] [Abstract][Full Text] [Related]
13. The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis.
Yee AJ; Akens M; Yang BL; Finkelstein J; Zheng PS; Deng Z; Yang B
Breast Cancer Res; 2007; 9(4):R47. PubMed ID: 17662123
[TBL] [Abstract][Full Text] [Related]
14. Cholecystokinin down-regulation by RNA interference impairs Ewing tumor growth.
Carrillo J; García-Aragoncillo E; Azorín D; Agra N; Sastre A; González-Mediero I; García-Miguel P; Pestaña A; Gallego S; Segura D; Alonso J
Clin Cancer Res; 2007 Apr; 13(8):2429-40. PubMed ID: 17438102
[TBL] [Abstract][Full Text] [Related]
15. Development of a preclinical orthotopic xenograft model of ewing sarcoma and other human malignant bone disease using advanced in vivo imaging.
Vormoor B; Knizia HK; Batey MA; Almeida GS; Wilson I; Dildey P; Sharma A; Blair H; Hide IG; Heidenreich O; Vormoor J; Maxwell RJ; Bacon CM
PLoS One; 2014; 9(1):e85128. PubMed ID: 24409320
[TBL] [Abstract][Full Text] [Related]
16. Expression of therapeutic targets in Ewing sarcoma family tumors.
Ahmed AA; Sherman AK; Pawel BR
Hum Pathol; 2012 Jul; 43(7):1077-83. PubMed ID: 22196127
[TBL] [Abstract][Full Text] [Related]
17. Deep Sequencing in Conjunction with Expression and Functional Analyses Reveals Activation of FGFR1 in Ewing Sarcoma.
Agelopoulos K; Richter GH; Schmidt E; Dirksen U; von Heyking K; Moser B; Klein HU; Kontny U; Dugas M; Poos K; Korsching E; Buch T; Weckesser M; Schulze I; Besoke R; Witten A; Stoll M; Köhler G; Hartmann W; Wardelmann E; Rossig C; Baumhoer D; Jürgens H; Burdach S; Berdel WE; Müller-Tidow C
Clin Cancer Res; 2015 Nov; 21(21):4935-46. PubMed ID: 26179511
[TBL] [Abstract][Full Text] [Related]
18. PRAS40 is a functionally critical target for EWS repression in Ewing sarcoma.
Huang L; Nakai Y; Kuwahara I; Matsumoto K
Cancer Res; 2012 Mar; 72(5):1260-9. PubMed ID: 22241085
[TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide inhibits Ewing's sarcoma cell invasiveness by targeting p38(MAPK) and c-Jun N-terminal kinase.
Zhang S; Guo W; Ren TT; Lu XC; Tang GQ; Zhao FL
Anticancer Drugs; 2012 Jan; 23(1):108-18. PubMed ID: 21946058
[TBL] [Abstract][Full Text] [Related]
20. Targeting the EWSR1-FLI1 oncogene-induced protein kinase PKC-β abolishes ewing sarcoma growth.
Surdez D; Benetkiewicz M; Perrin V; Han ZY; Pierron G; Ballet S; Lamoureux F; Rédini F; Decouvelaere AV; Daudigeos-Dubus E; Geoerger B; de Pinieux G; Delattre O; Tirode F
Cancer Res; 2012 Sep; 72(17):4494-503. PubMed ID: 22930730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
